Nanobiotix is trading $43.31, 10.23% up now, supported by broader biotech-sector strength.
- The stock rebounded from its September 1, 2026 close of $39.29.
- No new company-specific announcement was identified; Nanobiotix’s investor-relations page lists its latest 2026 release as a July 30 voting-rights filing.
- XBI is up 2.75%, helped by patent-related gains and positive industry momentum.